Historical record - last NADAC effective date: 1/20/2021
Product Information
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.4833 per EA under NDC 69097083105. Its NADAC has been published 233 times since Sep 14, 2016.
FDA first approved this application on Apr 20, 2011.
Strength
25; 20 mg/1; mg/1
Manufacturer
Cipla USA Inc.NDC
69097083105
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
1/20/2021
Active Ingredients
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201356FDA Approved
4/20/2011
On Market Since
7/20/2016
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has been published 233 times since Sep 14, 2016, and over the history we have for it it has declined 22.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4833 per EA |
|---|---|
| All-time high | $0.6222 (Sep 14, 2016) |
| All-time low | $0.3708 (May 17, 2017) |
| Median price | $0.4693 |
| Average price | $0.4780 |
| Largest weekly change | +28.4% (Jun 21, 2017) |
| Weeks tracked | 233 |
| Tracking since | Sep 14, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-22.3%
Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quinapril and Hydrochlorothiazide 20/25 market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quinapril and Hydrochlorothiazide 20/25 market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, manufactured by Cipla USA Inc., is $0.4833 per EA (NDC 69097083105), effective Feb 24, 2021.
How has the price of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB changed over time?
Over the history we have for it, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has declined 22.3%. It has been tracked across 233 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
Since Sep 14, 2016, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has ranged from a low of $0.3708 (May 17, 2017) to a high of $0.6222 (Sep 14, 2016), with a median of $0.4693 per EA.
Are there cheaper alternatives to QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
QUINAPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB (NDC 69097083105) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.